Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

NCT02496000 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: ORMD-0801
DRUG: Placebo Comparator

Sponsor

Oramed, Ltd.

Collaborators

[object Object]